000 01456 a2200421 4500
005 20250513075610.0
264 0 _c19931117
008 199311s 0 0 eng d
022 _a0022-5223
040 _aNLM
_beng
_cNLM
100 1 _aKirn, D H
245 0 0 _aMultimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging.
_h[electronic resource]
260 _bThe Journal of thoracic and cardiovascular surgery
_cOct 1993
300 _a696-702 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPneumonectomy
650 0 4 _aSurvival Analysis
700 1 _aLynch, T J
700 1 _aMentzer, S J
700 1 _aLee, T H
700 1 _aStrauss, G M
700 1 _aElias, A D
700 1 _aSkarin, A T
700 1 _aSugarbaker, D J
773 0 _tThe Journal of thoracic and cardiovascular surgery
_gvol. 106
_gno. 4
_gp. 696-702
999 _c8411538
_d8411538